These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9926660)

  • 21. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk?
    Andrade SE; Gurwitz JH
    J Am Geriatr Soc; 2002 Jan; 50(1):178-81. PubMed ID: 12028265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.
    Kennedy J; Tuleu I; Mackay K
    J Manag Care Pharm; 2008; 14(6):553-60. PubMed ID: 18693779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act.
    Bonakdar Tehrani A; Cunningham PJ
    Med Care; 2017 Jan; 55(1):43-49. PubMed ID: 27547949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outpatient prescription drug spending by the Medicare population.
    Waldo DR
    Health Care Financ Rev; 1987; 9(1):83-9. PubMed ID: 10312274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State-level variation in Medicare spending.
    Gage B; Moon M; Chi S
    Health Care Financ Rev; 1999; 21(2):85-98. PubMed ID: 11481788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of Medicare Part D on drug and medical spending.
    Zhang Y; Donohue JM; Lave JR; O'Donnell G; Newhouse JP
    N Engl J Med; 2009 Jul; 361(1):52-61. PubMed ID: 19571283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health insurance and health at age 65: implications for medical care spending on new Medicare beneficiaries.
    Hadley J; Waidmann T
    Health Serv Res; 2006 Apr; 41(2):429-51. PubMed ID: 16584457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in drug use and expenditures in a privately insured population of older adults.
    Correa-de-Araujo R; Miller GE; Banthin JS; Trinh Y
    J Womens Health (Larchmt); 2005; 14(1):73-81. PubMed ID: 15692281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicare Beneficiaries Face Growing Out-Of-Pocket Burden For Specialty Drugs While In Catastrophic Coverage Phase.
    Trish E; Xu J; Joyce G
    Health Aff (Millwood); 2016 Sep; 35(9):1564-71. PubMed ID: 27605634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.
    Stuart B; Doshi JA; Briesacher B; Wrobel MV; Baysac F
    Clin Ther; 2004 Oct; 26(10):1688-99. PubMed ID: 15598486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program.
    Bishop CE; Ryan AM; Gilden DM; Kubisiak J; Thomas CP
    Health Serv Res; 2009 Jun; 44(3):1010-28. PubMed ID: 19291168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the impact of coverage gaps in the Medicare Part D drug benefit.
    Hudson N
    Find Brief; 2008 Apr; 11(3):1-3. PubMed ID: 18441611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.
    Kilian J; Stubbings J
    J Manag Care Pharm; 2007; 13(1):59-65. PubMed ID: 17269838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics in drug coverage of Medicare beneficiaries: finders, losers, switchers.
    Stuart B; Shea D; Briesacher B
    Health Aff (Millwood); 2001; 20(2):86-99. PubMed ID: 11260962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
    Neuman P; Strollo MK; Guterman S; Rogers WH; Li A; Rodday AM; Safran DG
    Health Aff (Millwood); 2007; 26(5):w630-43. PubMed ID: 17711865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures.
    Ettner SL; Steers WN; Turk N; Quiter ES; Mangione CM
    J Gen Intern Med; 2011 Oct; 26(10):1195-200. PubMed ID: 21710313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription drug coverage for people with Medicare.
    Stein N
    Issue Brief Cent Medicare Educ; 2002; 3(9):1-8. PubMed ID: 12516561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries.
    Lewis JH; Schonlau M; Muñoz JA; Asch SM; Rosen MR; Yang H; Escarce JJ
    N Engl J Med; 2002 Mar; 346(11):830-5. PubMed ID: 11893795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.